ANM1, HCP1, HRMT1L2, IR1B4, INF receptor 1-bound protein 4, EC 2.1.1, Protein arginine N-methyltransferase 1, PRMT1, HMT2.
PRMT1 Human Recombinant (a.a. 1-353) fused with His-MBP tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 750 amino acids and having a molecular mass of 84 kDa.
The PRMT1 is purified by proprietary chromatographic techniques.
ANM1, HCP1, HRMT1L2, IR1B4, INF receptor 1-bound protein 4, EC 2.1.1, Protein arginine N-methyltransferase 1, PRMT1, HMT2.
PRMT1 is a type I methyltransferase that transfers a methyl group from S-adenosylmethionine to the guanidino nitrogens of arginine residues, forming monomethylarginine and asymmetric dimethylarginine . This enzyme is predominantly located in the nucleus and cytoplasm of human cells . PRMT1 is the major arginine methyltransferase in mammals, accounting for more than 85% of the arginine methylation activity .
PRMT1 is involved in a wide range of cellular processes, including:
PRMT1 interacts with several proteins that regulate its activity. For instance, the antiproliferative protein BTG1 (B-cell translocation gene 1) and hCAF1 (CCR4-associated factor 1) have been shown to modulate PRMT1 activity . These interactions highlight the enzyme’s role in the crosstalk between transcription and RNA processing .
Recombinant PRMT1 is a form of the enzyme produced through recombinant DNA technology, allowing for its use in research and therapeutic applications. This recombinant form retains the enzyme’s functional properties, making it a valuable tool for studying arginine methylation and its biological implications.